07 June 2012 Bioabsorbable polymer and drug eluting stents can reduce the risk of thrombosis intrastent to 4 years in patients undergoing coronary angioplasty primary. These results come from an analysis recently published on European Heart Journal. Data of individual patients from three randomised clinical trials, multicenter and large-scale (ISAR-TEST 3, ISAR-TEST 4, and LEADERS), Continue Reading